+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
NOVATEOR NOVATEOR

Novateor Research Laboratories Share Price

₹27.51 -4.49 (-14.03%)
42.69% Fall from 52W High

19 Nov, 2026 4:01 PM (IST)

Novateor Research Laboratories live price: ₹27.51. It opened at ₹28 vs previous close ₹32; intraday high/low: ₹28/₹28. The 50 & 200 DMA stand at ₹34.60/₹30.50.

Novateor Research Laboratories Performance

  • Today's Low
  • ₹28
  • Today's High
  • ₹28
  • 52 Week Low
  • ₹20
  • 52 Week High
  • ₹48
  • Open Price₹28
  • Previous Close₹32
  • Volume3,000
  • 50 DMA₹34.60
  • 100 DMA₹34.80
  • 200 DMA₹30.50

Novateor Research Laboratories Chart

Investment Returns

  • Over 1 Month -29.46%
  • Over 3 Month -16.26%
  • Over 6 Month -16.26%
  • Over 1 Year + 9.6%

Smart Investing Starts Here Start SIP with Novateor Research Laboratories for Steady Growth!

Invest Now

Novateor Research Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 164.5
  • PEG Ratio
  • -
  • Market Cap Cr
  • 17
  • P/B Ratio
  • 1.4
  • Average True Range
  • 3.6
  • EPS
  • 0.2
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.3
  • RSI
  • 41.48
  • MFI
  • 54.67

Latest Stock News Updates

Novateor Research Laboratories Ltd - 542771 - Unaudited Financial Results For The Half Year Ended On 30.09.2026

Unaudited Financial Results for the half year ended on 30.09.2026

Novateor Research Laboratories Ltd - 542771 - Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Half Year Ended On September 30, 2026

Meeting of Board of Directors is held today for approval Unaudited Financial Results for the half year ended on 30.09.2026

Novateor Research Laboratories Ltd - 542771 - Board Meeting Intimation for Adoption Of Unaudited Financial Results For The Half Year Ended On September 30, 2026

Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve unaudited financial results for the half year ended on September 30, 2026

Novateor Research Laboratories Financials

Novateor Research Laboratories Technicals

EMA & SMA

Current Price
₹27.51
-4.49 (-14.03%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹33.80
  • 50 Day
  • ₹34.60
  • 100 Day
  • ₹34.80
  • 200 Day
  • ₹30.50

Resistance and Support

27.5 Pivot Speed
  • R3 27.50
  • R2 27.50
  • R1 27.50
  • S1 27.50
  • S2 27.50
  • S3 27.50

Novateor Research Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-14 Half Yearly Results
2026-09-03 A.G.M.
2026-05-30 Audited Results
2025-11-14 Half Yearly Results
2025-09-03 A.G.M.

Novateor Research Laboratories Shareholding Pattern

50.75%
49.24%
0%

About Novateor Research Laboratories

Novateor Research Laboratories is an Indian research-focused public company specializing in the development, manufacturing, and marketing of novel oral care and personal care products View More
  • NSE Symbol
  • NOVATEOR
  • BSE Symbol
  • 542771
  • Executive Director,Managing Director,Chief Financial Officer
  • Navdeep Subhashbhai Mehta
  • ISIN
  • INE08JY01013

Similar Stocks to Novateor Research Laboratories

Novateor Research Laboratories FAQs

Novateor Research Laboratories share price is ₹27 As on 19 November, 2026 | 19:57

The Market Cap of Novateor Research Laboratories is ₹16.6 Cr As on 19 November, 2026 | 19:57

The P/E ratio of Novateor Research Laboratories is 164.5 As on 19 November, 2026 | 19:57

The PB ratio of Novateor Research Laboratories is 1.4 As on 19 November, 2026 | 19:57

The 52 week High & Low of Novateor Research Laboratories is ₹48/₹20.1 respectively As on 19 November, 2026 | 19:57

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23